Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Infection Surveillance Solutions Market, by Product and Services (Software, (On-Premises, Web-Based) and Services, (Support & Maintenance, Training & Consulting)), by Infection Type (Surgical Site Infections, Blood Stream Infections, Urinary Tract Infections) by End User (Hospitals, Clinics, Ambulatory Surgical Center, Other (Specialty Center, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Clinics, Ambulatory Surgical Center, Other (Specialty Center, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Infection surveillance solution is ... Read More
-
Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027
... anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to ... Read More
-
Middle East & Africa Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)
... and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, ... Read More
-
Molecular Diagnostic Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)—Global Forecast to 2030
... Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab)—Global Forecast to 2030. The molecular diagnostics market is expected to ... Read More
-
Digital PCR Market Forecasts to 2028 – Global Analysis By Product (Instruments, Reagents & Consumables and Other Products), Technology (Droplet Digital PCR, Chip-based Digital PCR and Other Technologies), Indication (Oncology, Infectious Diseases and Other Indications), Application (Oncology Testing, Blood Screening and Other Applications), End User and Geography
... Application (Oncology Testing, Blood Screening and Other Applications), End User and Geography According to Stratistics MRC, the Global Digital PCR Market is accounted for $539.73 million in 2022 and is expected to reach $2149.48 million ... Read More
-
Contract Research Organization (CRO) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines, Cell & Gene Therapy), End User & Region - Global Forecast to 2028
... The global CRO services market is estimated to grow at a CAGR of 10.7% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment ... Read More
-
Infectious Diseases In-Vitro Diagnostics Market Intelligence Report - Global Forecast 2023-2030
... CAGR 7.19% during the forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to ... Read More
-
Human Microbiome Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Big Pharma Players Striving To Gain Market Entry Through Collaboration ... Read More
-
2023 What's Next for Czech Republic Diagnostics Market? - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2022 supplier shares, strategies, as well as 2022-2027 volume and sales forecasts ... Read More
-
North America Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)
... Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and ... Read More
-
Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Other Products), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Biologics are medicines developed from blood, proteins, viruses, or living organisms, and are used to prevent, treat, and cure many health ... Read More
-
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Re
... immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028. Immunotherapy drugs ... Read More
-
Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 1,177.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028. Infection surveillance solutions assist healthcare personnel in collecting, analyzing, and interpreting data about patients who are suffering from different infections. ... Read More
-
North American URTI Market 2022-2028
... Group >18 to 400 Years, Age Group >40 to 65 Years, and Age Group >65 Years) Forecast, 2022-2028 Market Overview Upper respiratory tract infection (URTI) is a medical illness caused by an acute infection in ... Read More
-
Active Pharmaceutical Ingredients Market Size By Therapeutic Category (Oncology, Infectious Diseases, Anti-Diabetics, CNS & Anesthesia, Cardiovascular Diseases Biologics), By Synthesis (Chemical Based API, Biological API, Highly Potent API (HPAPI)), By Contract Outsourcing (CDMO, CMO), By Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032
... Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032 Global Active Pharmaceutical Ingredients Market is poised to grow significantly between 2023 and ... Read More
-
H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2023
... respiratory tract infections. Swine flu H1N1 infects the cells that line nose, throat and lungs. The virus enters body when contaminated droplets are inhaled or transfer live virus from a contaminated surface to eyes, nose ... Read More
-
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Drugs In Development, 2022, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) ... Read More
-
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Drugs In Development, 2022, provides an overview ... Read More
-
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Drugs In Development, 2022, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma ... Read More
-
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections - Drugs In Development, 2022, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape. Zika virus infection ... Read More
-
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis - Drugs In Development, 2022, provides an overview of the Poliomyelitis (Infectious Disease) pipeline landscape. Polio is a highly infectious disease caused by a virus. It ... Read More
-
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) - Drugs In Development, 2022, provides an overview of the Middle East Respiratory Syndrome ... Read More
-
MEA Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)
... Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others) The laboratory animal diets market ... Read More
-
South America Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)
... Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) The SAM lyophilized injectable market is expected to ... Read More
-
Europe Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)
... Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) The Europe lyophilized injectable market is expected to grow ... Read More
Research Assistance
